Simon Walker. (@TallSim) profile picture

You can find me on Bluesky

London and Oxfordshire
Joined March 2009
Photo by Simon Walker. (@TallSim)Photo by Simon Walker. (@TallSim)Photo by Simon Walker. (@TallSim)Photo by Simon Walker. (@TallSim)Photo by Simon Walker. (@TallSim)Photo by Simon Walker. (@TallSim)Photo by Simon Walker. (@TallSim)Photo by Simon Walker. (@TallSim)Photo by Simon Walker. (@TallSim)Photo by Simon Walker. (@TallSim)
Yet another @microsoft update that has banjaxed @Teams and in all my meetings today I seem to be in a badly dubbed Danish drama. Next tie please undergo your testing before releasing these updates please. This has taken up two hours of my life today
18
Replying to @GWRHelp
@GWRHelp what is going on with the trains between Oxford and Didcot this week? Today two rush hours trains cancelled from Oxford. The platforms are rammed and unsafe and there people have e had to move from platform 3 to 4 to 3 and back again. This is dangerous and unacceptable
2
229
Platforms are full. No staff visible and now the passengers from the cancelled trains will be rammed into a two carriage train that is due to leave at 1735.
19
Radley Station today! @GWRHelp @thameswater when are you going to sort this ongoing problem out?
2
210
Has Paddington Bear been out in charge of washing the Scottish rugby team’s away kit? #ITAvSCO
1
136
Simon Walker. retweeted
The number of predatory conferences is continuing to grow, and organizers are swift to change their practices to evade detection. Nature sent a reporter to one event to learn more... go.nature.com/3Ls1cJN
8
66
11
124
38,845
Simon Walker. retweeted
🦋 Today, on #WorldLupusDay, let's highlight the challenges faced by millions worldwide battling #lupus. Together, let's unite to raise awareness! For the latest updates and advancements in lupus research, visit 👉lupushub.com/. 💜 #SLE #WorldLupusDay2024 #LupusAwarenessMonth
5
17
880
Simon Walker. retweeted
Is Lupus Low Disease Activity State (LLDAS) attainment associated with favorable outcomes in patients with newly diagnosed SLE? Find out more and read an expert opinion by Mandana Nikpour here: loom.ly/qqO7JLQ @alberta_hoi @EricFMorand #MedTwitter #RheumTwitter #lupus
2
11
546
Our @gvhdhub Instagram account has launched! instagram.com/gvhd.hub?igsh=…
2
48
Simon Walker. retweeted
CONGRESS #LUPUS2024 | Daphna Paran from Tel Aviv Medical Center, Israel, presents ASSESSLE, a new disease activity score for #SLE. 45 pts were scored. ASSESSLE correlated well with BILAG & SLEDAI & showed similar ability to capture global, mucocutaneous, musculoskeletal & renal disease active domains. #Lupus #RheumTwitter #MedEd #medicalcongress
1
4
388
Simon Walker. retweeted
CONGRESS #LUPUS2024 | Gergely Bodor, University of Szeged, shares efficacy & safety of CYC vs RTX induction therapy in treating severe #SLE flare. After 12 months, more RTX- vs CYC-treated pts met remission criteria (41.9%% vs 14.8%; p=0.024) and received significantly lower induction & cumulative corticosteroid doses (p<0.001). AEs were numerically higher with CYC. #Lupus #RheumTwitter #MedEd #medicalcongress
1
1
6
814
Simon Walker. retweeted
CONGRESS #LUPUS2024 | Diogo Jesus @Hospital_Leiria presents a post-hoc analysis of ph II/III anifrolumab trials assessing ability of SLE-DAS to identify pts with MSDA (N=438). SLE-DAS identified 96.1% & SLEDAI-2K identified 92.9% of these pts. Pts in MSDA by SLE-DAS & SLEDAI-2K showed significantly severe impact all HR-QoL PROs. #Lupus #RheumTwitter #MedEd #medicalcongress
1
7
456
Simon Walker. retweeted
CONGRESS #LUPUS2024 | Emiliano Marasco @bambinogesu presents a case of refractory childhood-onset #SLE treated with anti-CD19 CAR T-cell therapy. CAR-T cells expanded significantly (peak at D12, 52 cells/uL), achieving complete B-cell depletion by D7. The patient remained in drug-free remission at the last follow-up (Wk10). #Lupus #RheumTwitter #MedEd #medicalcongress
1
6
332
Simon Walker. retweeted
CONGRESS #LUPUS2024 | @daniel_mrak @MedUni_Wien presents real-life drug survival rates in 235 pts with #SLE from Vienna #lupus cohort. The sequence of treatment cycles did now show significant association with overall drug survival, however type of treatment did: CQ/HCQ & MMF showed significantly higher retention rates compared to MTX & AZA (p=0.0016). #Lupus #RheumTwitter #MedEd #medicalcongress
1
7
538
Simon Walker. retweeted
CONGRESS #LUPUS2024 | Luxme Nadarajah @NHSBartsHealth presents efficacy of belimumab in pts with #Lupusnephritis refractory to standard therapy (N=12). At 1 yr, 72% pts did not see a fall in eGFR >20%, 40% had uPCR<0.7 g/mol & 58% had SLEDAI≤4. #Lupus #RheumTwitter #MedEd #medicalcongress
1
2
5
364
Simon Walker. retweeted
CONGRESS #LUPUS2024 | Mariele Gatto @unito discusses the minimum effective duration of clinical remission capable of protecting against damage accrual /development of impaired kidney function. The increase in SLICC damage index from baseline was significantly higher in pts who never achieved vs. those who achieved remission #Lupus #SLE #Rheumtwitter #medicalcongress
1
4
300
Simon Walker. retweeted
CONGRESS #LUPUS2024 | Ronald van Vollenhoven @ronfvv @UvA_Amsterdam presents post-hoc analysis of phase II PAISLEY trial assessing kinetics of mucocutaneous & musculoskeletal responses to deucravacitinib in pts with #SLE. More deucravacitinib-treated pts achieved SRI(4), CLASI-50, JC-50, & LLDAS responses than placebo-treated pts, with curve separation evident by Wk4. #Lupus #RheumTwitter #MedEd #medicalcongress
1
7
422
Simon Walker. retweeted
CONGRESS #LUPUS2024 | Takehiro Nakai from St. Luke’s International Hospital, Tokyo, discusses association between clinical remission with active serology/GC dosage on #SLE adverse pregnancy outcomes (N=96). Pregnant pts with clinical remission showed significantly decreased overall, maternal & neonatal APO ratio, while no statistical difference was observed based on serological activity. A prednisolone equivalent GC dose ≥7.5 mg/day at conception was associated with increased APO (p=0.016). #Lupus #RheumTwitter #MedEd #medicalcongress
1
3
412
Simon Walker. retweeted
CONGRESS #LUPUS2024 | Tamas Shisha presents interim findings of a phase 1/2 study (NCT05798117) of YTB323 in 6 pts with severe refractory #SLE. Peak expansion of CAR T-cells was observed at D13 & 18 in 2 pts. Safety profile was favourable: no ICANS were reported; CRS events were low-grade & reversible. Considerable reductions in SLEDAI & PhGA along with improvements in disease biomarkers were observed. #Lupus #RheumTwitter #MedEd #medicalcongress
1
4
457
Simon Walker. retweeted
CONGRESS #LUPUS2024 | Ismail Simsek presents preclinical studies discussing non-redundant roles of dual BAFF/APRIL inhibitor povetacicept vs single BAFF or APRIL inhibitors. Povetacicept had greater distribution to lupus-related tissues in normal mice, downregulated genes associated with B cell activation in cultured PBMC, and suppressed multiple disease parameters & key immune cell subsets in IFNα-accelerated NZB/W lupus model, compared to telitacicept or conventional B cell depletion. #Lupus #RheumTwitter #MedEd #medicalcongress
1
6
623